FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Respiratory topics
Respiratory
Ventilation
Respiratory Distress Syndrome
Executable
Computer Readable
Expiration
Respiration
Sleep Apnea
Medical Device
Continuous Positive Airway Pressure
Ventilator
Acute Respiratory Distress Syndrome
Antagonist
Cardiovascular Health
Cardiovascular

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Respiratory patents



      
           
This page is updated frequently with new Respiratory-related patent applications. Subscribe to the Respiratory RSS feed to automatically get the update: related Respiratory RSS feeds. RSS updates for this page: Respiratory RSS RSS


Methods and compositions for stabilizing dried biological materials

Lockheed Martin

Respiratory gas monitoring

Date/App# patent app List of recent Respiratory-related patents
01/29/15
20150032020
 Inhalation support  inhalation support patent thumbnailnew patent Inhalation support inhalation support
The invention relates to an inhalation support apparatus and the use thereof and to a method for supporting the inhalation of an inhalation mixture that is to be inhaled. The invention further relates to a device for the control of pressure changes, their use in the medical and non-medical field and a method for detecting respiratory problems..
01/29/15
20150032019
 End-tidal gas monitoring apparatus patent thumbnailnew patent End-tidal gas monitoring apparatus
A non-invasive monitoring apparatus for end-tidal gas concentrations, and a method of use thereof, is described for the detection of endogenous gas concentrations, including respiratory gases, in exhaled breath.. .
Fred Hutchinson Cancer Research Center
01/29/15
20150031645
 Methods of using human milk oligosaccharides for improving airway respiratory health patent thumbnailnew patent Methods of using human milk oligosaccharides for improving airway respiratory health
Disclosed are nutritional compositions including human milk oligosaccharides that can be administered to preterm infants, term infants, toddlers, and children for improving airway defense mechanisms.. .
Abbott Laboratories
01/29/15
20150031506
 Respiratory muscle endurance training device and  the use thereof patent thumbnailnew patent Respiratory muscle endurance training device and the use thereof
A respiratory muscle endurance training device (rmet) includes a chamber and a patient interface. In one implementation, one or both of a co, sensor or a temperature sensor can be coupled to the chamber or patient interface to provide the user or caregiver with indicia about the co, level in, or the temperature of, the chamber or patient interface, and/or the duration of use of the device.
Trudell Medical International
01/29/15
20150031016
 Mixed cell diagnostic systems for detection of respiratory, herpes and enteric viruses patent thumbnailnew patent Mixed cell diagnostic systems for detection of respiratory, herpes and enteric viruses
The present invention generally relates to the field of diagnostic microbiology, and, more particularly, to compositions and methods for detecting and differentiating one or more viruses or other intracellular parasites present in a specimen. The present invention also provides compositions and methods to evaluate the susceptibility of organisms to antimicrobial agents..
Diagnostic Hybrids Inc.
01/29/15
20150030629
 Methods and compositions for stabilizing dried biological materials patent thumbnailnew patent Methods and compositions for stabilizing dried biological materials
The present invention relates to methods for producing dried formulations of biopharmaceutical agents that aim to minimize the loss of activity of the agents upon drying and to provide dried formulations with an extended shelf life. The method comprises the step of drying an aqueous solution comprising, in addition to the biopharmaceutical agent, at least an amino acid, a polyol and a metal salt.
En Sport
01/29/15
20150030622
 Conformationally stabilized rsv pre-fusion f proteins patent thumbnailnew patent Conformationally stabilized rsv pre-fusion f proteins
In some embodiments, the present invention provides respiratory syncytial virus (rsv) f proteins, polypeptides and protein complexes that comprise one or more cross-links to stabilize the protein, polypeptide or protein complex in its pre-fusion conformation. In some embodiments the present invention provides rsv f proteins, polypeptides and protein complexes comprising one or more mutations to facilitate such cross-linking.
01/29/15
20150027446
 Respiratory protection mask patent thumbnailnew patent Respiratory protection mask
A respiratory protection mask (10) for alpine recreationalists, including a frame structure (14) that creates an air void (12) about a users mouth and nose and an outer covering (32) that creates a seal about the air void (12), the users mouth and nose. The mask (10) includes an inlet (20) for allowing air to be drawn into the air void (12) from external of the mask (10), and an outlet (26) for allowing exhaled air to be exhausted from the mask (10) at a location spaced from the inlet (20)..
01/29/15
20150027445
 Systems and methods for intra-pulmonary percussive ventilation integrated in a ventilator patent thumbnailnew patent Systems and methods for intra-pulmonary percussive ventilation integrated in a ventilator
System and methods for providing respiratory therapy include predetermined and/or automatically determined perturbations of levels of pressure, flow, and/or other gas parameters integrated and/or combined (start with a supplied pressurized flow of breathable gas for a subject. The perturbations are intended to improve secretion management through intra-pulmonary percussive ventilation integrated with ventilation therapy..
Koninklijke Philips N.v.
01/29/15
20150027444
 Bi-directional flow generation in an in-exsufflation system patent thumbnailnew patent Bi-directional flow generation in an in-exsufflation system
A bi-directional gas flow generation system (10), the system comprising: (a) a pressure generator (14) comprising an inlet (40) and an outlet (42), (b) a flow member (16) comprising an outlet port (50), an inlet port (52), a respiratory circuit port (54) and a flow path (60), (c) a first valve (18), (d) a second valve (20), and (e) a processor (24) configured to selectively control the first valve and the second valve to operate in (i) a first mode in which gas flows from the flow member inlet port (52) to the respiratory circuit port (54), thereby creating a positive pressure at the respiratory circuit port (54) to insufflate the subject; and (ii) a second mode in which gas flows from the respiratory circuit port (54) to the flow member outlet port (50), thereby facilitating gas flow out from the airway of the subject to exsufflate the subject.. .
Koninklijke Philips N.v.
01/29/15
20150027442
new patent

Respiratory gas monitoring


A device for monitoring gases present in a breathing mask. A gas sensing element carried by the breathing mask senses the partial pressure of a gas present in the breathing mask and outputs signals corresponding to the sensed gas partial pressure.
Lockheed Martin Corporation
01/29/15
20150027204
new patent

Respiratory gas humidification system


A humidification system comprises a first sensor and a second sensor. The first and second sensors are adapted to sense flow characteristics within the system.
Fisher & Paykel Healthcare Limited
01/22/15
20150025569

Auricular point stimulus device


The present invention provides an auricular point stimulus device, which includes a plate body. The plate body includes a plurality of bead protrusions formed thereon.
Zan Quan Technology Co., Ltd.
01/22/15
20150025405

Acute lung injury (ali)/acute respiratory distress syndrome (ards) assessment and monitoring


A patient is monitored for a medical condition such as acute lung injury (al1) by operations including: (i) receiving values of a plurality of physiological parameters for the patient; (ii) computing an al1 indicator value based at least on the received values of the plurality of physiological parameters for the patient; and (iii) displaying a representation of the computed al1 indicator value on a display (14, 22). The computing operation (ii) may employ various inference algorithms trained on a training set comprising reference patients to distinguish between reference patients having al1 and reference patients not having al1, or may employ an aggregation of two or more such inference algorithms.
Koninklijke Philips N.v.
01/22/15
20150024002

Alphavirus vectors for respiratory pathogen vaccines


Described herein are compositions and methods for stimulating an immune response to one or more proteins derived from one or more respiratory pathogens. In particular, the invention relates to alphavirus replicons, alphavirus vector constructs, alphavirus replicon particles expressing one or more antigens derived from one or more respiratory pathogens as well as to method of making and using these immunogenic compositions..
Novartis Vaccines And Diagnostics, Inc.
01/22/15
20150023985

Combination pharmaceutical composition and methods of treating diseases or conditions associated with respiratory disease or condition


The present invention is concerned with a combination pharmaceutical composition comprising a) an activated-potentiated form of an antibody to bradykinin, b) an activated-potentiated form of an antibody to histamine and c) an activated-potentiated form of an antibody to morphine and method for treating and preventing upper respiratory tract conditions or disorders and the symptoms associated therewith by administration of the combination composition.. .
01/22/15
20150023980

Combination pharmaceutical composition and methods of treating and preventing the infectious diseases


The present invention relates to a combination pharmaceutical composition comprising a) an activated-potentiated form of an antibody to at least one cytokine and b) an activated-potentiated form of an antibody to at least one receptor, and methods of treating and preventing the infectious diseases, including bacterial infections caused by different infectious agents such as pseudotuberculosis, whooping cough, yersiniosis, pneumonitis of different etiology, and acute and chronic viral infections such as acute respiratory tract infections, influenza of different types, acute viral hepatitis a, b, c and other types of hepatitis, the diseases and conditions caused by hiv or associated with hiv, including aids.. .
01/22/15
20150023972

Combination pharmaceutical composition and methods of treating and preventing the infectious diseases


The present invention relates to a combination pharmaceutical composition comprising a) an activated-potentiated form of an antibody to at least one cytokine and b) an activated-potentiated form of an antibody to at least one receptor, and methods of treating and preventing the infectious diseases, including bacterial infections caused by different infectious agents such as pseudotuberculosis, whooping cough, yersiniosis, pneumonitis of different etiology, and acute and chronic viral infections such as acute respiratory tract infections, influenza of different types, acute viral hepatitis a, b, c and other types of hepatitis, the diseases and conditions caused by hiv or associated with hiv, including aids.. .
01/22/15
20150020808

Methods and apparatus with improved ventilatory support cycling


A ventilator that delivers air at different pressures to a patient during inspiratory and expiratory cycles of breathing and that cycles from inspiratory to expiratory operation when the patient's respiratory flow passes a threshold level. The threshold generally increases form the beginning of inspiration to the end of inspiration.
Resmed Limited
01/15/15
20150018401

Novel ep4 agonist


Wherein r1 and r2 are each independently a hydrogen atom or a straight chain alkyl group having a carbon number of 1-3, r3 is a hydrogen atom, an alkyl group having a carbon number of 1-4, an alkoxyalkyl group, an aryl group, a halogen atom or a haloalkyl group, or a pharmaceutically acceptable salt thereof, which has, unlike known pgi2 analogs, a selective ep4 agonist action, and a medicament containing the compound, which is useful for the prophylaxis and/or treatment of immune diseases, diseases of the digestive tract, cardiovascular diseases, cardiac diseases, respiratory diseases, neurological diseases, ophthalmic diseases, renal diseases, hepatic diseases, bone diseases, skin diseases and the like.. .
01/15/15
20150018396

Prevention and treatment of respiratory infection with peroxisome proliferator activator receptor delta agonist


The present disclosure is related generally to a method for prevention and/or treatment of infections, e.g., respiratory infections, in a subject before or after the onset of a disease state associated with the infection.. .
President And Fellows Of Harvard College
01/15/15
20150018342

Fused pyrroledicarboxamides and their use as pharmaceuticals


The present invention relates to fused pyrroledicarboxamides of the formula (i), in which r1 to r9, x, m and n are as defined in the claims. The compounds of the formula (i) are inhibitors of the acid-sensitive potassium channel task-1 and suitable for the treatment of task-1 channel-mediated diseases such as arrhythmias, in particular atrial arrhythmias like atrial fibrillation or atrial flutter, and respiratory disorders, in particular sleep-related respiratory disorders like sleep apnea, for example..
Sanofi
01/15/15
20150018238

Multi-biomarker-based outcome risk stratification model for pediatric septic shock


Methods and compositions disclosed herein generally relate to methods of identifying, validating, and measuring clinically relevant, quantifiable biomarkers of diagnostic and therapeutic responses for blood, vascular, cardiac, and respiratory tract dysfunction, particularly as those responses relate to septic shock in pediatric patients. In particular, the invention relates to identifying one or more biomarkers associated with septic shock in pediatric patients, obtaining a sample from a pediatric patient having at least one indication of septic shock, then quantifying from the sample an amount of one or more of said biomarkers, wherein the level of said biomarker correlates with a predicted outcome.
Children's Hospital Medical Center
01/15/15
20150017150

Methods, compounds, and compositions for treatment and prophylaxis in the respiratory tract


The present invention provides a method of reducing the quanitity of mucus in the respiratory tract of a subject with elevated levels of mucus in said respiratory tract. The method includes administering to the subject a compound or composition containing a therapeutically effective amount of a fusion protein comprising a sialidase or an active portion thereof and an anchoring domain.
Ansun Biopharma, Inc.
01/15/15
20150017143

Composition comprising specific lactobacillus helveticus strains and reducing food and/or respiratory allergy symptoms


A composition comprising specific lactobacillus helveticus strains is provided for reducing the symptoms of allergies originating from food, respiratory or contact allergens. Preferably the composition reduces symptoms of allergies (secondary prevention) while also able to reduce sensitization (primary prevention)..
Nestec S.a.
01/15/15
20150017104

Compositions, methods & systems for respiratory delivery of two or more active agents


Compositions, methods and systems are provided for pulmonary or nasal delivery of two or more active agents via a metered dose inhaler. In one embodiment, the compositions include a suspension medium, active agent particles, and suspending particles, in which the active agent particles and suspending particles form a co-suspension within the suspension medium..
Pearl Therapeutics, Inc.
01/15/15
20150017099

Diagnosis and treatment for respiratory tract diseases


The invention provides methods and compositions for the diagnosis, prognosis and treatment of respiratory tract diseases. Specifically, the invention provides diagnosis, prognosis and treatment of respiratory infections using bitter and sweet taste signal transduction pathways.
The Trustees Of The University Of Pennsylvania
01/15/15
20150013681

Apparatus with exhaust spacer to improve filtration of pathogens in respiratory emissions of sneezes


Apparatus and method to mitigate the spread of respiratory emission of a sneeze are disclosed. The apparatus includes a spacer component and at least one filtration component.
01/15/15
20150013679

Ventilatory assistance for treatment of cardiac failure and cheyne-stokes breathing


Method and apparatus for the treatment of cardiac failure, cheyne stokes breathing or central sleep apnea are disclosed. A subject is provided with ventilatory support.
Resmed Limited
01/15/15
20150013671

Huff cough simulation device


A respiratory treatment device having an inlet configured to receive exhaled air into the device and an outlet configured to permit exhaled air to exit the device. A blocking member is moveable between a closed position where the flow of air through the device is restricted, and an open position where the flow of air through the device is less restricted.
Trudell Medical International
01/08/15
20150011905

Respiratory cycle patient ventilation flow limitation detection


A single respiratory cycle flow limitation detection method is disclosed. A patient gas delivery signal is received from one or more sensors in pneumatic communication with a ventilation source and a patient ventilation interface to a patient airway.
Breathe Technologies, Inc.
01/08/15
20150011840

Event sequencing using acoustic respiratory markers and methods


Disclosed are systems and methods for detecting e.g. Physiological, pathophysiological and therapeutic events, and characterizing the temporal relationship between these events and acoustic respiratory markers..
Isonea (israel) Limited
01/08/15
20150011612

Rnai modulation of rsv and therapeutic uses thereof


The present invention is based on the in vivo demonstration that rsv can be inhibited through intranasal administration of irna agents as well as by parenteral administration of such agents. Further, it is shown that effective viral reduction can be achieved with more than one virus being treated concurrently.
Alnylam Pharmaceuticals, Inc.
01/08/15
20150011363

Respiratory muscle endurance training device and the use thereof


A respiratory muscle endurance training device (rmet) includes a chamber and a patient interface. In one implementation, one or both of a co2 sensor or a temperature sensor can be coupled to the chamber or patient interface to provide the user or caregiver with indicia about the co2 level in, or the temperature of, the chamber or patient interface, and/or the duration of use of the device.
Trudell Medical International
01/08/15
20150011017

Diagnosis and risk stratification by means of the novel marker ct-proadm


The invention relates to a novel diagnostic marker ct-proadm (c-terminal fragment of preproadm, seq id no. 1) for diagnosing and/or stratifying the risk of diseases.
Brahms Gmbh
01/08/15
20150010618

Guanosine-rich oligonucleotide (gro) compositions, methods and uses for treating respiratory syncytial virus infection


Provided herein is a method of treating respiratory syncytial virus (rsv) infection in a cell. The method involves administering the guanosine-rich oligonucleotide (gro) as 1411 (5′-ggtggtggtgg ttgtggtggtggtgg-3′—also known as gr026b and agro100) to the cell..
University Of Toronto
01/08/15
20150010527

Dnase i polypeptides, polynucleotides encoding same, methods of producing dnase i and uses thereof in therapy


Plant-expressed human recombinant dnase proteins, nucleic acid constructs for expression of the human recombinant dnase i in plant cells, cells expressing the nucleic acid construct and therapeutic uses thereof are disclosed. Particularly, compositions and methods for treating pulmonary and/or respiratory conditions by inhalation of the plant-expressed human recombinant dnase i are provided..
Protalix Ltd.
01/08/15
20150007824

Lever adjustment assembly for mask


A respiratory interface device is provided that includes a mask (10) and a brace (40) assembly. The mask has a faceplate (12) and a cushion (15), and the brace assembly has a brace body (42) and a lever assembly (44).
Koninklijke Philips N.v.
01/08/15
20150007823

Method for calibrating the level of oxygen in respiratory gas related to the level of oxygen in the blood circulation of an individual


The present invention relates to a method for calibrating, or adjusting, the level of oxygen in respiratory gas related to the level of oxygen in the blood circulation of the individual, comprising providing a level of oxygen in the gas flow passing into, or out, of the respiratory system of the individual and producing a corresponding first output, providing a level of oxygen in the blood circulation of the individual and producing a corresponding second output, providing a computer for receiving and storing at least two measurements, each measurement being the concurrent output of said first output and said second output within a data structure, in which the two stored outputs are mutually related, in data storage means associated with the computer, the at least two measurements being conducted at respective levels of oxygen in the gas flow passing into the respiratory system, and calibrating the level of oxygen in the gas value in response to a delay between the level of oxygen in the blood circulation of the individual and the level of oxygen in the gas flow passing into, or out, of the respiratory system of the individual.. .
Mermaid Care A/s
01/08/15
20150007820

Breathing circuit device


The invention relates to a respiratory circuit appliance with a respiratory line, a co2 absorber (6) in the respiratory line, and a cooling device for cooling the respiratory gas after it exits the co2 absorber. Provision is made that the cooling device cools a heating pump with a compressor (33) for compressing/condensing a cooling medium, a condenser (30), which receives the condensed cooling medium, and in so doing releases heat to the surroundings, and with a heat exchanger body (8) which receives the cooled cooling medium and is in heat-conducting contact with a section of the respiratory line..
Dräger Safety Ag & Co. Kgaa
01/01/15
20150005658

Apparatus for determining respiratory condition


An apparatus for determining a respiratory condition, includes: a signal acquiring section which is configured to acquire a signal corresponding to a respiratory flow of a subject; a first index producing section which is configured to produce a first index related to the respiratory flow of the subject obtained from the signal; a second index producing section which is configured to produce a second index related to a respiratory demand of the subject predicted from the first index; a third index producing section which is configured to produce a third index related to a respiratory effort of the subject based on the first index and the second index; and an outputting section which is configured to output the third index.. .
Nihon Kohden Corporation
01/01/15
20150005647

Method and system for estimating momentary cardiovascular performance reserve


The invention relates to a method for determining a cardiovascular performance reserve for each individual patient, comprising the steps of: a) receiving input physiological data from the patient for obtaining a parameter z which is or approximates the product of the stroke volume (sv) by the systemic vascular resistance (svr); b) providing a value representing the respiratory rate (rr) of said patient, wherein the respiratory rate (rr) value is provided by measurements using dedicated device(s), calculations from the input physiological data or manually by using best estimate; c) providing anthropometric data of said patient for calculating the body surface area (bsa) of said individual, wherein the anthropometric data includes at least body dimensions (such as height and weight) of said patient; d) calculating the cardiovascular reserve (cvr) by using said z parameter and said rr according to following formula: cvr=(z/rr); e) calculating a cardiovascular reserve index (cvri) by standardizing said cvr (by said bsa) and normalizing it to a scale of 1 according to the following formula: cvri=cvr/(bsa*4); and outputting said cardiovascular reserve index.. .
Cardio Scale Ltd.
01/01/15
20150005639

On-airway pulmonary function tester


A compact, on-airway, respiratory gas analyzer for performing pulmonary function tests incorporates an ir spectroscopy light guide having a curved, rather than linear, sample chamber that lies transverse to a direction of respiratory gas flow. Cooperating with the sample chamber is an impact plate that functions to steer respiratory and test gases impinging on the impact plate into the curved sample chamber.
Mgc Diagnostics Corporation
01/01/15
20150005189

Multi-biomarker-based outcome risk stratification model for adult septic shock


Methods and compositions disclosed herein generally relate to methods of identifying, validating, and measuring clinically relevant, quantifiable biomarkers of diagnostic and therapeutic responses for blood, vascular, cardiac, and respiratory tract dysfunction, particularly as those responses relate to septic shock in adult patients. In particular, the invention relates to identifying one or more biomarkers associated with septic shock in adult patients, obtaining a sample from an adult patient having at least one indication of septic shock, then quantifying from the sample an amount of one or more of said biomarkers, wherein the level of said biomarker correlates with a predicted outcome.
Children's Hospital Medical Center
01/01/15
20150004155

Rsv g protein specific antibodies


The disclosure relates to human isolated, synthetic or recombinant antibodies or functional parts thereof, specific for the rsv g protein. Antibodies specific for the rsv g protein are particularly suitable for counteracting rsv and symptoms, such as inflammation, resulting from an rsv infection.
Aimm Therapeutics B.v.


Popular terms: [SEARCH]

Respiratory topics: Respiratory, Ventilation, Respiratory Distress Syndrome, Executable, Computer Readable, Expiration, Respiration, Sleep Apnea, Medical Device, Continuous Positive Airway Pressure, Ventilator, Acute Respiratory Distress Syndrome, Antagonist, Cardiovascular Health, Cardiovascular

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Respiratory for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Respiratory with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         





0.6793

3643

70 - 0 - 71